ProPhase Labs
ProPhase Labs, Inc.
ProPhase Labs is a diversified company operating in biotechnology, genomics, and consumer health. After a history in consumer products and a recent pivot to COVID-19 testing, the company is now focusing its strategy on the commercialization of advanced health solutions. Its main initiatives include an esophageal cancer diagnostic test and direct-to-consumer whole genome sequencing services.
Products & Team
BE-Smart™ Esophageal Cancer Test
BE-Smart™ is a diagnostic test designed for the early detection of esophageal cancer in patients who have been diagnosed with Barrett's Esophagus, a pre-cancerous condition. The test analyzes protein expression from a small biopsy sample to assess the patient's risk of progression to cancer.
It provides clinicians with a tool to better assess the risk of cancer in patients with Barrett's Esophagus, enabling more informed decisions for patient monitoring and potential early intervention.
The company addresses the clinical need for better risk stratification in pre-cancerous conditions, the consumer's curiosity about personal genetics and health predispositions, and the general desire for over-the-counter wellness solutions for energy and vitality.